BACKGROUND: Ewing Sarcoma Family Tumours (ESFT) are rare in early childhood. The aim of this study was to report the clinical characteristics and outcome of children under 6 years of age affected by ESFT of the bone in Italy. METHODS: The records of all the children diagnosed with osseous ESFT in centres members of the Associazione Italiana di Ematologia ed Oncologia Pediatrica (AIEOP) from 1990 to 2008 were reviewed. The Kaplan-Meier method was used for estimating overall and progression-free survival (OS, PFS) curves; multivariate analyses were performed using Cox proportional hazards regression model. RESULTS: This study includes 62 patients. An axial primary localization was present in 66% of patients, with the primary site in the...
Primary bone tumours account for less than 0.2% of all neoplasms but malignant bone tumours represen...
OBJECTIVE: To outline the epidemiological profile and prognosis for Ewing's sarcoma in the Brazilian...
Aims: To evaluate OS and EFS of paediatric sarcoma patients with an interest in comparing metastatic...
BACKGROUND: Ewing Sarcoma Family Tumours (ESFT) are rare in early childhood. The aim of this study w...
Background: Ewing Sarcoma Family Tumours (ESFT) are rare in early childhood. The aim of this study w...
Abstract Background: Ewing Sarcoma Family Tumours (ESFT) are rare in early childhood. The aim of th...
Aim: Ewing’s Sarcoma Family Tumors (ESFT) is rare in early childhood. We investigated the clinical c...
Background: Osteosarcoma (OS) and Ewing’s Sarcoma (ES) are the two most common malignant bone tumors...
ABSTRACTObjective: To outline the epidemiological profile and prognosis for Ewing's sarcoma in the B...
Ewing’s sarcoma (ES) is the second most common malignant bone tumor accounting for 5-10% of malignan...
Simple Summary Younger age has been associated with better overall survival in Ewing sarcoma, especi...
Ewing sarcoma is an aggressive mesenchymal malignancy. It is the second most common bone tumor among...
Aim: The aim of this study is to review of the clinical characteristics and outcome of children with...
Ewing sarcoma (ES) is the second most frequent primary malignant bone cancer, following osteosarcoma...
Ewing’s sarcoma is the second most common malignant tumor of the bone occurring in children and adol...
Primary bone tumours account for less than 0.2% of all neoplasms but malignant bone tumours represen...
OBJECTIVE: To outline the epidemiological profile and prognosis for Ewing's sarcoma in the Brazilian...
Aims: To evaluate OS and EFS of paediatric sarcoma patients with an interest in comparing metastatic...
BACKGROUND: Ewing Sarcoma Family Tumours (ESFT) are rare in early childhood. The aim of this study w...
Background: Ewing Sarcoma Family Tumours (ESFT) are rare in early childhood. The aim of this study w...
Abstract Background: Ewing Sarcoma Family Tumours (ESFT) are rare in early childhood. The aim of th...
Aim: Ewing’s Sarcoma Family Tumors (ESFT) is rare in early childhood. We investigated the clinical c...
Background: Osteosarcoma (OS) and Ewing’s Sarcoma (ES) are the two most common malignant bone tumors...
ABSTRACTObjective: To outline the epidemiological profile and prognosis for Ewing's sarcoma in the B...
Ewing’s sarcoma (ES) is the second most common malignant bone tumor accounting for 5-10% of malignan...
Simple Summary Younger age has been associated with better overall survival in Ewing sarcoma, especi...
Ewing sarcoma is an aggressive mesenchymal malignancy. It is the second most common bone tumor among...
Aim: The aim of this study is to review of the clinical characteristics and outcome of children with...
Ewing sarcoma (ES) is the second most frequent primary malignant bone cancer, following osteosarcoma...
Ewing’s sarcoma is the second most common malignant tumor of the bone occurring in children and adol...
Primary bone tumours account for less than 0.2% of all neoplasms but malignant bone tumours represen...
OBJECTIVE: To outline the epidemiological profile and prognosis for Ewing's sarcoma in the Brazilian...
Aims: To evaluate OS and EFS of paediatric sarcoma patients with an interest in comparing metastatic...